Skip to content
Skip to library content

Category 18

Emerging Research and Future Developments

12 topics planned. Each topic is published as a Professional and Patient edition only after explicit author approval.

  • 18.1MSC engineering
    In preparation
    1. · Genetic modification
    2. · RNA engineering
    3. · Surface modification
    4. · Homing enhancement
    5. · Suicide switches
    6. · Safety controls
  • 18.2MSC priming
    In preparation
    1. · Hypoxia
    2. · Inflammatory cytokines
    3. · Mechanical stimulation
    4. · Pharmacological priming
    5. · Three-dimensional culture
    6. · Disease-specific conditioning
  • 18.3Advanced manufacturing
    In preparation
    1. · Closed automated systems
    2. · Continuous manufacturing
    3. · Large-scale bioreactors
    4. · Real-time monitoring
    5. · Process analytical technology
    6. · Artificial intelligence in quality control
  • 18.4Engineered EVs
    In preparation
    1. · Cargo loading
    2. · Surface targeting
    3. · RNA delivery
    4. · Protein delivery
    5. · Drug delivery
    6. · Synthetic and hybrid vesicles
  • 18.5EV biomarkers
    In preparation
    1. · Cancer detection
    2. · Neurological disease
    3. · Cardiovascular disease
    4. · Transplant monitoring
    5. · Treatment response
    6. · Liquid biopsy
  • 18.6Tissue engineering
    In preparation
    1. · Biomaterial scaffolds
    2. · Hydrogels
    3. · Decellularized matrix
    4. · Bioprinting
    5. · Vascularized constructs
    6. · Organoid transplantation
  • 18.7Pluripotent-cell-derived therapies
    In preparation
    1. · Retinal cells
    2. · Dopaminergic neurons
    3. · Cardiomyocytes
    4. · Pancreatic beta cells
    5. · Immune cells
    6. · Safety and tumorigenicity
  • 18.8Organoids and disease models
    In preparation
    1. · Developmental biology
    2. · Drug screening
    3. · Personalized medicine
    4. · Toxicology
    5. · Organoid transplantation
    6. · Ethical issues
  • 18.9Precision regenerative medicine
    In preparation
    1. · Patient stratification
    2. · Biomarker-guided therapy
    3. · Pharmacogenomics
    4. · Immune profiling
    5. · Digital endpoints
    6. · Individualized potency testing
  • 18.10Better clinical trials
    In preparation
    1. · Adaptive designs
    2. · Platform trials
    3. · Master protocols
    4. · Standardized core outcomes
    5. · International registries
    6. · Long-term surveillance networks
  • 18.11Future regulatory challenges
    In preparation
    1. · Engineered cells
    2. · Combination products
    3. · Decentralized manufacturing
    4. · Personalized batches
    5. · Artificial EVs
    6. · Cross-border treatment
  • 18.12Realistic future outlook
    In preparation
    1. · Scientific opportunities
    2. · Translational bottlenecks
    3. · Manufacturing barriers
    4. · Affordability
    5. · Evidence requirements
    6. · Preventing hype from outrunning data